eriodictyol has been researched along with Bile Duct Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binti Morshidi, NAA; Byeon, JH; Han, SI; Hong, YY; Jin, SB; Jung, Y; Kim, JH; Lee, J; Sim, W | 1 |
1 other study(ies) available for eriodictyol and Bile Duct Cancer
| Article | Year |
|---|---|
Eriodictyol Attenuates Cholangiocarcinoma Malignancy by Regulating HMOX1 Expression: An
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Flavanones; Heme Oxygenase-1; Humans; RNA, Small Interfering | 2022 |